Deborah Kilpatrick
Fortuna: 648 $ al 30/06/2026
Fortuna: 648 $ al 30/06/2026
Deborah L.
Kilpatrick is currently an Independent Director at Sleep Number Corp.
since 2018, Director at Sutter Health since 2024, Director at Jupiter Endovascular, Inc., Director at Dystonia Medical Research Foundation, Director at NextGen Jane, Inc., and Venture Partner at Sonder Capital Management LLC since 2024.
Former roles include Executive Chairman & Co-Chief Executive Officer at Evidation Health, Inc. from 2014 to 2024, Director-Research & Technology Development at Guidant Corp.
from 1998 to 2006, and Chief Commercial Officer at CardioDx, Inc. from 2013 to 2014.
Education includes undergraduate, graduate, and doctorate degrees from Georgia Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SLEEP NUMBER CORPORATION 0,12 % | 21/05/2026 | 27.571 ( 0,12 % ) | 648 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SLEEP NUMBER CORPORATION | Director/Miembro de la Junta | 09/05/2018 |
Dystonia Medical Research Foundation | Director/Miembro de la Junta | - |
NextGen Jane, Inc.
NextGen Jane, Inc. Medical SpecialtiesHealth Technology Develops proprietary tampon systems to analyze menstrual blood | Director/Miembro de la Junta | - |
Sonder Capital Management LLC
Sonder Capital Management LLC Investment ManagersFinance Sonder Capital invests in medical technology startups located in the United States. The firm targets companies operating in the fields of life-changing healthcare technologies. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 01/01/2024 |
Sutter Health
Sutter Health Medical/Nursing ServicesHealth Services Operates as an online healthcare networking platform | Director/Miembro de la Junta | 01/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Evidation Health, Inc.
Evidation Health, Inc. Packaged SoftwareTechnology Services Develops mobile application that delivers healthcare rewards points based on health performance | Director Ejecutivo | 01/01/2024 |
| CARDIODX INC | Corporate Officer/Principal | 01/01/2014 |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Corporate Officer/Principal | 01/01/2006 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Sleep Number Corp.
Sleep Number Corp. Home FurnishingsConsumer Durables Manufactures air and specialty mattresses | Consumer Durables |
CardioDx, Inc.
CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Evidation Health, Inc.
Evidation Health, Inc. Packaged SoftwareTechnology Services Develops mobile application that delivers healthcare rewards points based on health performance | Technology Services |
Georgia Institute of Technology
Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sutter Health
Sutter Health Medical/Nursing ServicesHealth Services Operates as an online healthcare networking platform | Health Services |
Dystonia Medical Research Foundation | |
Sonder Capital Management LLC
Sonder Capital Management LLC Investment ManagersFinance Sonder Capital invests in medical technology startups located in the United States. The firm targets companies operating in the fields of life-changing healthcare technologies. It provides financing for early stage capital requirements. | Finance |
NextGen Jane, Inc.
NextGen Jane, Inc. Medical SpecialtiesHealth Technology Develops proprietary tampon systems to analyze menstrual blood | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.